Prostatis Group’s Amplify CWP Enhanced Dividend Income ETF DIVO Stock Holding History
Bought
Maintained
Sold
Other funds holding DIVO
RPGK
Prostatis Group's DIVO Position: Q1 2026 in Review
Prostatis Group increased its Amplify CWP Enhanced Dividend Income ETF (DIVO) stake by 2.3% in Q1 2026, buying an estimated $493K and bringing the position to 468,993 shares worth $21M. The position accounts for 5.38% of the portfolio, ranked #2.
Prostatis Group first reported a position in DIVO in Q1 2021 and has held it in 21 quarters since. 383 funds tracked by Wall St. Rank hold DIVO as of Q1 2026.
- Prostatis Group held 468,993 shares of Amplify CWP Enhanced Dividend Income ETF worth $21M as of Q1 2026.
- Prostatis Group bought 10,765 Amplify CWP Enhanced Dividend Income ETF shares in Q1 2026, an estimated $493K.
- Amplify CWP Enhanced Dividend Income ETF made up 5.38% of Prostatis Group's portfolio in Q1 2026, its #2 holding.
- Prostatis Group first reported a position in Amplify CWP Enhanced Dividend Income ETF in Q1 2021 and has held it in 21 quarters since.
- 383 funds tracked by Wall St. Rank held Amplify CWP Enhanced Dividend Income ETF as of Q1 2026.
Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.